[HTML][HTML] Heart failure: a class review of pharmacotherapy
A Shah, D Gandhi, S Srivastava, KJ Shah… - Pharmacy and …, 2017 - ncbi.nlm.nih.gov
Heart Failure: A Class Review of Pharmacotherapy - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …
[HTML][HTML] An update on the pathophysiology and treatment of cardiorenal syndrome
R Raina, N Nair, R Chakraborty, L Nemer… - Cardiology …, 2020 - ncbi.nlm.nih.gov
Cardiorenal syndrome (CRS) encompasses various disorders of the heart and kidneys;
dysfunction of one organ leads to acute or chronic dysfunction of the other. It incorporates …
dysfunction of one organ leads to acute or chronic dysfunction of the other. It incorporates …
Guideline‐directed medical therapy for heart failure does not exist: a non‐judgmental framework for describing the level of adherence to evidence‐based drug …
Numerous guideline documents have issued recommendations to clinicians concerning the
treatment of chronic heart failure and a reduced ejection fraction. However, guidelines do …
treatment of chronic heart failure and a reduced ejection fraction. However, guidelines do …
2011 update to National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand Guidelines for the prevention, detection and management of …
H Krum, MV Jelinek, S Stewart… - Medical journal of …, 2011 - Wiley Online Library
Chronic heart failure (CHF) is a complex and lethal clinical syndrome accounting for an
increasing number of Australian hospital separations and more than 2700 Australian deaths …
increasing number of Australian hospital separations and more than 2700 Australian deaths …
Novel therapeutic targets for the treatment of heart failure
J Tamargo, J Lopez-Sendon - Nature reviews Drug discovery, 2011 - nature.com
Despite considerable therapeutic advances, heart failure remains a medical and
socioeconomic problem. Thus, there is a compelling need for new drugs that could improve …
socioeconomic problem. Thus, there is a compelling need for new drugs that could improve …
Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design …
H Krum, B Massie, WT Abraham… - European journal of …, 2011 - Wiley Online Library
Aims The renin–angiotensin–aldosterone system (RAAS) represents a key therapeutic
target in heart failure (HF) management. However, conventional agents that block this …
target in heart failure (HF) management. However, conventional agents that block this …
Парадигма коморбидности: синтропия ХОБЛ и ИБС
МА Куценко, АГ Чучалин - РМЖ, 2014 - elibrary.ru
СМЕЖНЫЕ ПРОБЛЕМЫ ПУЛЬМОНОЛОГИИ ство подобных исследований на
небольших группах пациентов не позволяет считать данный вопрос достаточно …
небольших группах пациентов не позволяет считать данный вопрос достаточно …
Impact of systolic blood pressure on the safety and tolerability of initiating and up‐titrating sacubitril/valsartan in patients with heart failure and reduced ejection fraction …
Aims The TITRATION trial investigated two strategies to initiate and up‐titrate
sacubitril/valsartan (LCZ696) to the same target dose, over a condensed (3‐week) or …
sacubitril/valsartan (LCZ696) to the same target dose, over a condensed (3‐week) or …
Incidence, predictors, and outcomes associated with hypotensive episodes among heart failure patients receiving sacubitril/valsartan or enalapril: the PARADIGM-HF …
O Vardeny, B Claggett, J Kachadourian… - Circulation: Heart …, 2018 - Am Heart Assoc
Background: In PARADIGM-HF (Prospective Comparison of Angiotensin Receptor
Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on …
Neprilysin Inhibitor With Angiotensin-Converting Enzyme Inhibitor to Determine Impact on …
[HTML][HTML] Angiotensin-converting enzyme and heart failure
S Álvarez-Zaballos, M Martínez-Sellés - Frontiers in Bioscience …, 2023 - imrpress.com
Pharmacotherapy is the cornerstone treatment for patients with heart failure (HF) that uses
drugs targeting the renin-angiotensin-aldosterone system (RAAS), including angiotensin …
drugs targeting the renin-angiotensin-aldosterone system (RAAS), including angiotensin …